Clinical Trials
29 trialsInternational Pediatric Adrenocortical Tumor Registry
St. Jude Children's Research Hospital
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
St. Jude Children's Research Hospital
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
National Institutes of Health Clinical Center (CC)
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
LUPARPED
Fundación de investigación HM
Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
Emory University
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
PARTNER
Azienda Ospedaliera di Padova
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
Latin American Cooperative Oncology Group
Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma
M.D. Anderson Cancer Center
CaboACC
Wuerzburg University Hospital
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
University Hospital Olomouc
Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)
National Institutes of Health Clinical Center (CC)
CASE
Shanghai Jiao Tong University School of Medicine
VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma
Humanitas Clinical and Research Center
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Novartis
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Corcept Therapeutics
Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
Northwestern University
Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors
Bnai Zion Medical Center
Circulating Tumor DNA Exposure in Peripheral Blood
Quantgene Inc.
Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
Dartmouth-Hitchcock Medical Center
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Vanderbilt-Ingram Cancer Center
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Corcept Therapeutics
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Corcept Therapeutics
SEISMIC
Corcept Therapeutics
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
National Institutes of Health Clinical Center (CC)
Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer
National Institutes of Health Clinical Center (CC)
adrenal
Istanbul University